The “observer of my own life” feeling: depersonalization vs emotional blunting on antidepressants

Why does it feel like you’re watching your life from outside yourself?

You sit at dinner and the food has no texture. A friend tells a story and you laugh in the right places without feeling the laugh. A song you loved sounds like background noise. Or maybe it is sharper than that — you feel like an observer of your own life, watching yourself act from a few feet behind your eyes. Many people experience some version of this on antidepressant medication, and many people do not know what to call it. Without language, it is harder to find help.

This article is for clarifying what you are experiencing, not diagnosing it. Four overlapping experiences come up in the patient + clinical literature for adults on SSRIs and SNRIs: emotional blunting, depersonalization, apathy, and anhedonia. They share family resemblance but they are not the same. For the cornerstone explainer on emotional blunting specifically, see When antidepressants work but you don’t feel like yourself. For practices that re-anchor presence between appointments, see How to feel present when antidepressants flatten you.

What is emotional blunting?

Emotional blunting is the reduced intensity of both positive AND negative emotions while on antidepressant medication. The original prevalence study found 46% of antidepressant-treated patients reported it (n=669) [Goodwin et al., 2017, Journal of Affective Disorders]. Subsequent reviews put the range at 40-60% across SSRI and SNRI users. The 2023 University of Cambridge study led by Sahakian and colleagues identified the mechanism: antidepressants reduce reinforcement learning, so rewarding signals (a kind word, a good meal) get less weight in the brain’s updating process [Sahakian et al., 2023, University of Cambridge].

Ma, Cai and Wang 2021 in Frontiers in Psychiatry frame blunting as reduced emotional reactivity that often appears or intensifies AFTER depression symptoms have improved on medication [Ma, Cai & Wang, 2021, Frontiers in Psychiatry]. That timing pattern distinguishes medication-induced blunting from depression-related flat affect. For the full explainer, see When antidepressants work but you don’t feel like yourself.

What is depersonalization, and how is it different?

Depersonalization is a disruption in the felt sense of being the one having your experience. People describe it as “watching myself from outside,” “life feels unreal,” or “I am here but I am not the one here.” Derealization is the related experience where the surrounding world feels unreal. The Jin et al. 2023 systematic review in PMC found prevalence of 5-20% in outpatient settings, with higher rates of 17.5-41.9% among inpatients with specific mental-health disorders [Jin et al., 2023, PMC depersonalization-derealization systematic review].

The key distinction from blunting is what gets affected. Blunting reduces emotion intensity: emotions arrive but quieter. Depersonalization disrupts the sense of being the one having the experience: emotions may be at full volume but feel like they are happening to someone else. A person can experience both at once. The clinical literature documents rare cases of SSRI-induced persistent depersonalization; the more common pattern is transient episodes that resolve when stressors change.

What about apathy and anhedonia? Are they the same thing?

They are related but distinct. Apathy is reduced motivation and initiative — you do not do the thing, even when you can think of reasons to. It is more a behavioral pattern than a felt-emotion change. Argyropoulos and colleagues 2013 in Psychopharmacology distinguish reward-system symptoms from mood symptoms partly on this pattern [Argyropoulos et al., 2013, Psychopharmacology]. Anhedonia is reduced pleasure specifically — positive emotions are dimmed while negative emotions may still be present. Anhedonia is a core diagnostic criterion of depression itself.

The crucial distinction from emotional blunting: blunting is broader — both positive and negative emotions are dimmed roughly equally — and it often follows depression remission rather than overlapping with it. Many people on SSRIs experience their depression lift and then notice the blunting arriving as a separate experience [Psychopharmacology Institute clinical guidance]. Anhedonia tends to travel with the rest of unresolved depression symptoms; blunting tends to appear alongside otherwise improved symptoms.

How do I know which one I’m experiencing?

Three quick checks. None of these is diagnostic; they are self-recognition prompts to help you find more accurate language for what you are feeling.

Timing check. Did this start or worsen after your medication began or after a dose change? That timing points more toward medication-induced blunting. Has it persisted across mood states, including before medication? That pattern could point toward depersonalization, which is not specifically medication-bound.

Quality check — which sentence fits best? “I don’t feel things as strongly” → blunting. “I’m here but it’s like watching a movie of my life” → depersonalization. “I don’t want to do anything” → apathy. “Things I used to enjoy don’t feel good anymore” → anhedonia. The Oxford Depression Questionnaire (ODQ) is one validated instrument prescribers use to characterize blunting specifically [Goodwin et al., 2017, Journal of Affective Disorders + Oxford Depression Questionnaire].

The honest framing. These are not mutually exclusive. The 2021 PMC review of long-term SSRI side effects documents emotional blunting as among the most-supported effects but frequently presenting alongside apathy or anhedonia [PMC, 2021, SSRI long-term side effects review]. The Lewis MD clinical guide describes the 40-60% prevalence range with the “watching life through glass” descriptor [Lewis, MD, clinical guide on antidepressant emotional blunting]. You may have more than one. The point of the language is accurate description, not a single label.

What should I do once I have the language for what I’m feeling?

For practices that re-anchor present-moment awareness between appointments — the body-anchored interoception work that helps when blunting or detachment is the closest fit — see the companion article How to feel present when antidepressants flatten you. For the cornerstone explainer on emotional blunting itself, see When antidepressants work but you don’t feel like yourself.

Transient detachment is common, especially under stress or after dose changes, and a brief sense of unreality usually resolves on its own. Persistent depersonalization is different and warrants a more urgent clinical conversation than blunting alone would. If your experience is persistent, intensifying, or accompanied by suicidal thoughts, severe functional impairment, or significant relationship or work disruption, talk to your prescriber. Bring specific language: “I feel outside myself” vs “I feel flat” vs “I cannot make myself start things” help your prescriber characterize what is happening. Do not change your dose or stop your medication without clinical input.

Frequently asked questions

Sources

1. Goodwin, G. M., et al. (2017). Emotional blunting with antidepressant treatments. Journal of Affective Disorders, 221, 31-35. PubMed 28628765
2. Sahakian, B. J., et al. (2023). Antidepressants reduce reinforcement learning. University of Cambridge. Cambridge research news
3. Ma, H., Cai, M., & Wang, H. (2021). Emotional blunting in patients with major depressive disorder: a brief non-systematic review. Frontiers in Psychiatry. Frontiers in Psychiatry
4. Jin, Y., et al. (2023). Prevalence of depersonalization- derealization disorder: systematic review. PMC systematic review
5. Argyropoulos, S. V., et al. (2013). On the antidepressant effect of SSRIs in anhedonia. Psychopharmacology. Psychopharmacology
6. Psychopharmacology Institute. Clinical guidance on antidepressant-induced emotional blunting: distinguishing from apathy and residual depression. Psychopharmacology Institute
7. Lewis, B., MD. Clinical guide on antidepressant emotional blunting (40-60% prevalence range, "watching life through glass" patient descriptor).
8. Price, J., Cole, V., & Goodwin, G. M. (2009). Oxford Depression Questionnaire (ODQ). British Journal of Psychiatry, 195(3), 211-217. PubMed 19721109
9. PMC (2021). Long-term SSRI side effects review — emotional blunting as the most-supported side effect. PMC review